These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 1468183

  • 1. Effects of thymosin and insulin on suppressor T cell in type 1 diabetes.
    Wang SH, Chen G, Zhang K.
    Diabetes Res; 1992 Jan; 19(1):21-9. PubMed ID: 1468183
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus.
    Pozzilli P, Zuccarini O, Sensi M, Spencer KM, Bottazzo G.
    Biomed Biochim Acta; 1984 Jan; 43(5):621-5. PubMed ID: 6236800
    [Abstract] [Full Text] [Related]

  • 3. Suppressor cell responses in patients with rheumatoid arthritis: the effect of thymosin.
    Zatz MM, Oliver J, Goldstein AL, Novak C, Jacobs RP.
    Thymus; 1984 Jan; 6(4):205-18. PubMed ID: 6238454
    [Abstract] [Full Text] [Related]

  • 4. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO, Goyal D, Ahvazi B, Yoon JW, Chung YH, Bagg A, Harlan DM.
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [Abstract] [Full Text] [Related]

  • 5. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM, Murray SL, Kershnar A, Mosier MA.
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.
    Hersey P, Ho K, Werkmeister J, Abele U.
    Clin Exp Immunol; 1981 Nov; 46(2):340-9. PubMed ID: 6461457
    [Abstract] [Full Text] [Related]

  • 7. Multiparameter immunologic studies in patients with newly diagnosed type 1 insulin-dependent diabetes mellitus.
    Gupta S, Charles MA, Waldeck N, Kershnar A, Buckingham B.
    Diabetes Res; 1986 Jun; 3(5):225-9. PubMed ID: 2943547
    [Abstract] [Full Text] [Related]

  • 8. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies.
    Mascart-Lemone F, Delespesse G, Dorchy H, Lemiere B, Servais G.
    Clin Exp Immunol; 1982 Feb; 47(2):296-300. PubMed ID: 6210472
    [Abstract] [Full Text] [Related]

  • 9. Suppressor T cell activation by human leukocyte interferon.
    Schnaper HW, Aune TM, Pierce CW.
    J Immunol; 1983 Nov; 131(5):2301-6. PubMed ID: 6226738
    [Abstract] [Full Text] [Related]

  • 10. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I, Fabien N, Thivolet C.
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [Abstract] [Full Text] [Related]

  • 11. CD11B lymphocytes in type 1 diabetes mellitus of recent onset.
    Bizzarro A, De Bellis A, Amoresano Paglionico V, Auletta M, Gattoni A, Altucci P, Iacono G.
    Horm Metab Res Suppl; 1992 Jul; 26():121-2. PubMed ID: 1490677
    [Abstract] [Full Text] [Related]

  • 12. In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.
    Marshall GD, Thurman GB, Rossio JL, Goldstein AL.
    J Immunol; 1981 Feb; 126(2):741-4. PubMed ID: 6161188
    [Abstract] [Full Text] [Related]

  • 13. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC, Ruibal Ares B, Baliña LM, Valdez R, Bachmann AE.
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [Abstract] [Full Text] [Related]

  • 14. Defective suppressor cell generation in juvenile onset diabetes.
    Lederman MM, Ellner JJ, Rodman HM.
    J Immunol; 1981 Nov; 127(5):2051-5. PubMed ID: 6457859
    [Abstract] [Full Text] [Related]

  • 15. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
    Fischer A, Le Deist F, Durandy A, Griscelli C.
    J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
    [Abstract] [Full Text] [Related]

  • 16. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E, Toge T, Tanada M, Hamamoto S, Seto Y, Kohno H, Hattori T.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
    [Abstract] [Full Text] [Related]

  • 17. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
    Buschard K.
    Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
    [Abstract] [Full Text] [Related]

  • 18. A cell surface monoclonal antibody (H366) helps to discriminate human cytotoxic from suppressor T cells.
    Al-Sakkaf L, Pozzilli P, Sensi M, Irving WL, Bottazzo GF.
    Clin Exp Immunol; 1985 Dec; 62(3):594-9. PubMed ID: 2935341
    [Abstract] [Full Text] [Related]

  • 19. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO, Röder A, Fröhlich J.
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [Abstract] [Full Text] [Related]

  • 20. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
    Fairchild RS, Kyner JL, Abdou NI.
    J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.